Oral antiviral molnupiravir gets interim authorisation for Covid-19 treatment in S'pore
It will be prescribed and prioritised for those at higher risk of severe illness. . Read more at straitstimes.com.
Stay updated with breaking news from Miami Based Ridgeback. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
It will be prescribed and prioritised for those at higher risk of severe illness. . Read more at straitstimes.com.
The government previously said the ban will be lifted once 90 per cent of adults are fully vaccinated.. Read more at straitstimes.com.
The move is part of the country's preparations to transition towards the endemic phase, says its Health Minister.. Read more at straitstimes.com.
SINGAPORE - The Republic has inked a supply and purchase agreement for an antiviral pill to treat Covid-19 that is said to be effective against all known variants of the virus, including the Delta variant. The drug was developed by pharmaceutical firm Merck in the United States and Canada, together with Miami-based Ridgeback Biotherapeutics. Merck is known as MSD elsewhere...
Molnupiravir will be available here once it has received authorisation and approval for use.. Read more at straitstimes.com.